FLESHER GREGORY J.
Insider CIK 1705287 · NVUS Chief Executive Officer, Director · RPHM President and CEO, Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| RPHM Reneo Pharmaceuticals, Inc | A Award deriv | 2022-12-09 | 2022-12-13 | 300,000 | — | $0 | 300,000 | SEC↗ |
| RPHM Reneo Pharmaceuticals, Inc | A Award deriv | 2021-12-10 | 2021-12-14 | 200,000 | — | $0 | 200,000 | SEC↗ |
| RPHM Reneo Pharmaceuticals, Inc | A Award | 2021-12-10 | 2021-12-14 | 100,000 | — | $0 | 109,600 | SEC↗ |
| RPHM Reneo Pharmaceuticals, Inc | P Buy | 2021-08-25 | 2021-08-26 | 8,000 | $8.00 | $64.0K | 8,000 | SEC↗ |
| NVUS Novus Therapeutics, Inc. | A Award deriv | 2020-03-19 | 2020-03-20 | 200,000 | — | $0 | 200,000 | SEC↗ |
| NVUS Novus Therapeutics, Inc. | A Award deriv | 2019-09-26 | 2019-09-30 | 100,000 | — | $0 | 100,000 | SEC↗ |
| NVUS Novus Therapeutics, Inc. | S Sale | 2019-05-21 | 2019-05-22 | 2,937 | $1.91 | $5.6K | 156,918 | SEC↗ |
| NVUS Novus Therapeutics, Inc. | S Sale | 2019-05-20 | 2019-05-22 | 11,701 | $1.96 | $22.9K | 159,855 | SEC↗ |
| NVUS Novus Therapeutics, Inc. | A Award deriv | 2019-03-14 | 2019-03-18 | 90,000 | — | $0 | 90,000 | SEC↗ |
| NVUS Novus Therapeutics, Inc. | A Award | 2019-03-14 | 2019-03-18 | 25,000 | — | $0 | 171,556 | SEC↗ |
| NVUS Novus Therapeutics, Inc. | A Award deriv | 2018-03-13 | 2018-03-15 | 56,500 | — | $0 | 56,500 | SEC↗ |
| NVUS Novus Therapeutics, Inc. | A Award | 2018-03-13 | 2018-03-15 | 30,700 | — | $0 | 146,556 | SEC↗ |
| NVUS Novus Therapeutics, Inc. | A Award deriv | 2017-05-24 | 2017-05-26 | 250,000 | — | $0 | 250,000 | SEC↗ |
| NVUS Novus Therapeutics, Inc. | P Buy | 2017-05-10 | 2017-05-11 | 58,959 | $9.99 | $589.0K | 115,856 | SEC↗ |